[HTML][HTML] The few who made it: commercially and clinically successful innovative bone grafts

…, P Procter, IY Bozo, RV Deev… - … in bioengineering and …, 2020 - frontiersin.org
Bone reconstruction techniques are mainly based on the use of tissue grafts and artificial
scaffolds. The former presents well-known limitations, such as restricted graft availability and …

pCMV-vegf165 Intramuscular Gene Transfer is an Effective Method of Treatment for Patients With Chronic Lower Limb Ischemia

RV Deev, IY Bozo, ND Mzhavanadze… - Journal of …, 2015 - journals.sagepub.com
Effective treatment of chronic lower limb ischemia is one of the most challenging issues
confronting vascular surgeons. There are a number of choices available to the vascular surgeon. …

[HTML][HTML] Ordinary and activated bone grafts: applied classification and the main features

RV Deev, AY Drobyshev, IY Bozo… - BioMed Research …, 2015 - hindawi.com
Bone grafts are medical devices that are in high demand in clinical practice for substitution
of bone defects and recovery of atrophic bone regions. Based on the analysis of the modern …

Bioceramics composed of octacalcium phosphate demonstrate enhanced biological behavior

VS Komlev, SM Barinov, II Bozo, RV Deev… - … applied materials & …, 2014 - ACS Publications
Bioceramics are used to treat bone defects but in general do not induce formation of new
bone, which is essential for regeneration process. Many aspects related to bioceramics …

[HTML][HTML] 3D printing of octacalcium phosphate bone substitutes

…, IV Smirnov, IY Bozo, VA Rybko, RV Deev - … in bioengineering and …, 2015 - frontiersin.org
Biocompatible calcium phosphate ceramic grafts are able of supporting new bone formation
in appropriate environment. The major limitation of these materials usage for medical …

[HTML][HTML] 3D printed gene-activated octacalcium phosphate implants for large bone defects engineering

IY Bozo, RV Deev, IV Smirnov, AY Fedotov… - … journal of bioprinting, 2020 - ncbi.nlm.nih.gov
The aim of the study was the development of three-dimensional (3D) printed gene-activated
implants based on octacalcium phosphate (OCP) and plasmid DNA encoding VEGFA. The …

[HTML][HTML] World's first clinical case of gene-activated bone substitute application

IY Bozo, RV Deev, AY Drobyshev, AA Isaev… - Case reports in …, 2016 - hindawi.com
Treatment of patients with large bone defects is a complex clinical problem. We have
initiated the first clinical study of a gene-activated bone substitute composed of the collagen-…

[HTML][HTML] Bringing a gene-activated bone substitute into clinical practice: From bench to bedside

…, NA Redko, VS Komlev, AA Isaev, RV Deev - … in Bioengineering and …, 2021 - frontiersin.org
Bone grafting and reconstruction are still challenging in clinical practice because of the
limitations of bone autografts and the drawbacks of currently approved bone substitutes. We thus …

In vitro assessment of electrospun polyamide‐6 scaffolds for esophageal tissue engineering

…, MJ Holterman, M Mavlikeev, RV Deev… - … Research Part B …, 2019 - Wiley Online Library
Artificial tissue‐engineered grafts offer a potential alternative to autologous tissue grafts for
patients, which can be traumatic. After decellularizing Papio hamadryas esophagus and …

[HTML][HTML] Magnetic resonance imaging pattern variability in dysferlinopathy

…, EN Berezhnaya, IA Yakovlev, AA Isaev, RV Deev - Acta …, 2021 - ncbi.nlm.nih.gov
The widespread use of magnetic resonance imaging (MRI) in the diagnosis of myopathies
has made it possible to clarify the typical MRI pattern of dysferlinopathy. However, sufficient …